The Trump administration confirmed it is reevaluating a $590 million human bird flu vaccine contract awarded to Moderna in the waning days of the Biden administration. “While it is crucial

With egg prices soaring, the US is considering vaccinating laying chickens, which have been hit particularly hard by the avian influenza outbreak.

Both the Finnish and the U.S. bird flu vaccines are made by CSL Seqirus but are different vaccines. In the summer, U.S. officials stockpiled 4.8 million doses of the vaccine that officials said was effective against circulating H5N1 strains. In October, the U.S. issued a $72 million grant to three manufacturers to double the nation's stockpile.